Nava Limited Stocks

623.25Last Updated 15.04.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

₹ 1.84B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
623.25
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nava Limited engages in the ferro alloys, power, mining, and healthcare businesses in India, Zambia, Hong Kong, Japan, and internationally. It generates and sells power using coal, biomass, biogas, and bagasse. The company operates 150 MW and 114 MW power plants in Paloncha, Telangana; 150 MW power plant in Kharagprasad, Odisha; 20 MW biomass power plant in Dharmavaram, Andhra Pradesh; and 300 MW thermal power plant in Zambia. It also mines coal at Maamba in Southern province of Zambia, as well as provides operation and maintenance services for power plants. In addition, the company various alloy metals, such as ferro chrome, silico manganese, ferro silicon, and chromium alloys that are used in automotive, railways, and construction industries, as well as in the manufacture of stainless-steel consumer goods. Further, it operates a medical clinic for the management of iron deficiency and the administration of intravenous iron in Singapore. Additionally, the company manages The Iron Suites Medical Center and corporate healthcare programmes; organizes medical congresses and awareness programmes; and in-licenses pharmaceutical products. The company was formerly known as Nava Bharat Ventures Limited and changed its name to Nava Limited in July 2022. Nava Limited was incorporated in 1972 and is based in Hyderabad, India.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks